Abstract: A semiconductor device including fin field-effect transistors, includes a first gate structure extending in a first direction, a second gate structure extending the first direction and aligned with the first gate structure in the first direction, a third gate structure extending in the first direction and arranged in parallel with the first gate structure in a second direction crossing the first direction, a fourth gate structure extending the first direction, aligned with the third gate structure and arranged in parallel with the second gate structure, an interlayer dielectric layer disposed between the first to fourth gate electrodes, and a separation wall made of different material than the interlayer dielectric layer and disposed between the first and third gate structures and the second and fourth gate structures.

Abstract: A method for controlling transmission control protocol performance in a wireless network is provided. The method is used in a server device and the server device is in communication with a client device based on a TCP connection. The method includes receiving a plurality of packets from a TCP layer in the server device. The method includes storing the packets in a buffer, recording the packets in a transmission list, and forwarding the packets to the client device, wherein each packet has a packet sequence number. In response to receiving a packet acknowledgment message sent from the client device, the method includes determining a packet loss rate of the client device based on the packet acknowledgment message. The method includes dynamically adjusting a congestion window size of the TCP connection based on the packet loss rate to control a transmission rate of the TCP layer.

Abstract: The disclosure includes compounds of Formula (1)-(4) wherein each of Warhead, R1, R2, R3, L1, L2, L3, L4, L5, L6, R, Q1, Q2, Q3, W1, W2, m, n, and i, are defined herein. Also disclosed is a method for treating a neoplastic disease, autoimmune disease, and inflammatory disorder with these compounds.

Abstract: Provides a flexible copper clad laminate, which includes a polyimide substrate; a nickel-copper alloy layer; and a copper layer. The nickel-copper alloy layer is formed on at least one side of the polyimide substrate by electroless plating and comprises at least nickel, copper and phosphorus. A content of the copper is more than 30 wt % of the nickel-copper alloy layer, a content of the phosphorus is less than 5 wt % of the nickel-copper alloy layer, and a corrosion potential of the nickel-copper alloy layer in a 0.02 vol % sulfuric acid solution is greater than ?20 mV. The copper layer is formed on a side of the nickel-copper alloy layer away from the polyimide substrate and combined with the nickel-copper alloy layer to form a metal conductive layer. In addition, the aforementioned flexible copper clad laminate has electrochemical corrosion resistance and sufficient peel strength, facilitating the production of flexible printed circuit boards.

Abstract: A cathode material includes a Mo-doped sodium metal phosphate represented by Na4Mn1-xMoxV(PO4)3, in which x is greater than 0 and x is 0.2 or less. A sodium ion battery includes a cathode, an anode, a separator between the cathode and the anode, and an organic electrolyte, in which the cathode includes the cathode material. The cathode material has the advantage of low cost and easy preparation and also has the performance of high capacity under high current density when applied to the sodium ion battery.

Abstract: The present disclosure provides an air duct structure to receive a processing component. The air duct structure includes an air inlet opening, an air outlet opening, a plurality of side walls, and a support surface. The air inlet opening is in direct fluid communication with an air inlet of the computer chassis. The air outlet opening is in direct fluid communication with an air inlet of a processing component. The plurality of side walls at least partially define a channel extending between the air inlet opening and the air outlet opening. The support surface receives the processing component on the air duct structure relative to the computer chassis. The processing component includes an air exhaust to diffuse air, and the plurality of side walls at least partially fluidly isolate the air inlet opening from an air diffused from the air exhaust.

Abstract: A device structure includes a first electrode overlying a substrate; a node dielectric contacting the first electrode and including a dielectric material having a dielectric constant greater than 30; and a second electrode contacting the node dielectric. A first one of the first electrode and the second electrode includes a first catalytic metal plate in direct contact with the node dielectric and having a first electronegativity that is not greater than an electronegativity of molybdenum.

Abstract: A solid-state electrolyte of a lithium-ion battery is provided. The lithium-ion battery has a negative electrode including a lithium-containing material in contact with the solid-state electrolyte. The solid-state electrolyte includes a multiple-doping material with a chemical formula of LixTiyMm(PO4)3, wherein 0.8?x?1.5, 0<y?0.6, M represents at least three different doping elements, 1.25?m?1.7, and y/m?0.5. The lithium-ion battery using the solid-state electrolyte is also provided.

Abstract: The disclosure includes compounds of any one of Formulae (0)-(5), (11)-(24), (A)-(E), and (1)-(V) comprising an E3 ubiquitin ligase binding moiety that binds an E3 ubiquitin ligase, as described herein. Also disclosed pharmaceutical compositions comprising compounds, and a method for treating a neoplastic disease, autoimmune disease, and inflammatory disorder with these compounds.

Abstract: A neural network circuit includes an input neuron layer comprises a plurality of first neurons. A hidden neuron layer includes a plurality of second neurons, wherein each of the second neurons comprises a probabilistic bit having a time-varying resistance. The probabilistic bit is a magnetic tunnel junction structure comprises a pinned layer, a free layer, and a tunneling barrier layer between the pinned layer and the free layer. A weight matrix comprising a plurality of synapse units, each of the synapse units connecting one of the plurality of first neurons to a corresponding one of the plurality of first neurons.

Abstract: Provided are an anti-Her-2 antibody-granulocyte regulatory factor fusion protein, a preparation method therefor and an application thereof. Specifically, this relates to a fusion protein, a single chain of the fusion protein comprising the following elements fused together: (a) a first protein element; (b) a second protein element; and (c) optionally, a joint element located between the first protein element and the second protein element. The first protein element is an antigen recognition module, for example, a protein element of an anti-Her-2 antibody or an active fragment thereof; the second protein element is a granulocyte colony stimulating factor. The present fusion protein has advantages in precise recognition, immunotherapy, controllable toxicity, and enhanced ADCC, and also has the synergistic effect of high-efficiency tumor cell killing activity, as well as low toxicity and side effects.

Abstract: A directional coupler includes a main path, a coupling path, a first port, and a second port. The main path is used to propagate a first RF signal. The coupling path at least partially overlaps with the main path. The coupling path includes a first end, a second end, and at least one winding routed between the first end and the second end. The first port is coupled to the first end of the coupling path. The second port is coupled to the second end of the coupling path. At least one of the first port and the second port is located inside the at least one winding.

Abstract: The present invention relates to crystalline forms of a KRas G12C inhibitor and salt thereof. In particular, the present invention relates to crystalline forms of the KRas G12C inhibitor 2-[(2S)-4-[7-(8-chloro-1-naphthyl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile, pharmaceutical compositions comprising the crystalline forms, processes for preparing the crystalline forms and methods of use thereof.

Abstract: A power divider and an electronic device are provided. The power divider includes: a main port having an input characteristic admittance; a first output port having a first characteristic admittance; a second output port having a second characteristic admittance, where the second and the first characteristic admittances have a predetermined ratio relationship; a first adjustment branch coupled between the main port and the first output port; and a second adjustment branch coupled between the main port and the second output port. The input characteristic admittance is a sum of admittances presented by the first and second adjustment branches at the main port. The admittance presented by the first adjustment branch at the main port and the admittance presented by the second adjustment branch at the main port are adjustable and the input characteristic admittance is enabled to be equal to a sum of the first and the second characteristic admittances.

Abstract: The present invention provides a speaker box including a housing and a speaker unit accommodated in the housing. The speaker box also includes an air-permeable spacer accommodated in the housing. The housing includes a bottom wall away from the speaker unit and a side wall bent and extended from the bottom wall toward the speaker unit. The air-permeable spacer is enclosed with the bottom wall and the side wall to form a containment space filled with sound absorbing powder. The inner surface of the side wall is provided with a number of protruding portions that support the air-permeable spacer. The air-permeable spacer is fixedly connected with the protruding portion. The speaker box of the present invention saves internal space and increases the filling amount of the sound absorbing powder.

Abstract: The disclosure includes compounds of Formula (1), wherein each of RA, RB, R1, R2, R3, R4, Warhead, Z, Q4, W1, W2, m, n, i, and j, are defined herein. Also disclosed is a method for treating a neoplastic disease, autoimmune disease, and inflammatory disorder with these compounds.

Abstract: Embodiments of the present disclosure provide a bond stage for bonding a semiconductor integrated circuit (IC) die. The bond stage includes a bonding platform having a top surface and a bottom surface opposing the top surface, a first actuator operable to tilt the bonding platform about a first rotation axis, and a plurality of contact sensors disposed at the bonding platform.

Abstract: The present invention relates to crystalline forms of a KRas G12C inhibitor and salt thereof. In particular, the present invention relates to crystalline forms of the KRas G12C inhibitor 2-[(2S)-4-[7-(8-chloro-1-naphthyl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile, pharmaceutical compositions comprising the crystalline forms, processes for preparing the crystalline forms and methods of use thereof.

Abstract: The present invention provides a speaker box including a housing and a speaker unit accommodated in the housing. The speaker box also includes an air-permeable spacer accommodated in the housing. The housing includes a bottom wall away from the speaker unit and a side wall bent and extended from the bottom wall toward the speaker unit. The air-permeable spacer is enclosed with the bottom wall and the side wall to form a containment space filled with sound absorbing powder. The inner surface of the side wall is provided with a number of protruding portions that support the air-permeable spacer. The air-permeable spacer is fixedly connected with the protruding portion. The speaker box of the present invention saves internal space and increases the filling amount of the sound absorbing powder.